Several studies have shown a correlation between iNOS expression and tumor stage progression in malignant melanoma [119,120], poor survival in colorectal cancer [118,121], poor prognosis in estrogen receptor (ER)-negative breast cancer patients [122,123], and lymph node metastasis in pancreatic cancer [124]. Here, NOS2 is linked to breast carcinoma.